This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Andre C Dumetz: Innovator in Antibody Purification
Introduction
Andre C Dumetz is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of biotechnology, particularly in the purification of antibodies. His innovative methods have the potential to enhance the efficiency of antibody production, which is crucial for various therapeutic applications.
Latest Patents
Andre C Dumetz holds a patent for "Methods for purifying antibodies." This invention relates to a method of purifying a recombinant polypeptide from Host Cell Proteins (HCP). The method involves applying a solution containing the recombinant polypeptide and HCP to a superantigen chromatography solid support. It also includes washing the support with a wash buffer comprising caprylate and arginine, followed by eluting the recombinant polypeptide from the solid support. This patent showcases his expertise in developing advanced purification techniques.
Career Highlights
Andre is associated with GlaxoSmithKline Intellectual Property Development Limited, where he applies his knowledge and skills to further research and development in the pharmaceutical industry. His work focuses on improving the processes involved in antibody production, which is vital for the development of new therapies.
Collaborations
Throughout his career, Andre has collaborated with esteemed colleagues, including Kent E Goklen and Nicholas E Levy. These partnerships have allowed him to enhance his research and contribute to significant advancements in the field.
Conclusion
Andre C Dumetz is a prominent figure in the biotechnology sector, recognized for his innovative methods in antibody purification. His contributions are paving the way for more efficient therapeutic developments.